Company News-Guangzhou DiQi Pharmaceuticals Co., Ltd

Home

About Us

Technology Platform

Product Center

Service and Support

Collaboration Mode

News

Join Us

News

Company News

Filter:

All years

All years 2017 2018 2019 2020 2021 2022 2023 2024 2025

2023/08/16DiQi Pharma B0125 Receives Approval for Clinical Trial Application (IND) in China

On August 2, 2023, Guangzhou DiQi Pharmaceuticals Co., Ltd. received the Clinical Trial Approval Notice (Nos. 2023LP01572 and 2023LP01573) from the CDE for its independently developed Class II innovative drug B0125. This product is indicated for the treatment of diabetic peripheral neuropathic pain (DPNP).
2023/07/25“One Meter of Sunshine” Precision Interactive Class Commences at DiQi Pharma

To enhance communication skills among employees at DiQi Pharma, the “One Meter of Sunshine” Precision Interaction Workshop was held at the company on the afternoon of July 21, 2023.
2023/03/08Goddess Day Celebration: Honoring and Empowering Women’s Strength

Female employees are an indispensable part of DiQi Pharma. Working across R&D, functional management, and other roles, they drive the achievement of our goals while steadily advancing their own professional growth! To express our gratitude for their contributions, DiQi Pharma has organized a “Joyful Women's Day” celebration today.
2023/02/13In the Name of Youth, Answer the Call of Passion

Recently, employees of Guangzhou DiQi Pharmaceuticals Co., Ltd. actively participated in the “In the Name of Youth, Answer the Call of Blood” voluntary blood donation campaign. Together, they answered the call to donate blood, extending a helping hand to patients in urgent need of transfusions.
2023/02/08Good News – DiQi Pharma Recognized as a “Specialized, Refined, Distinctive, and Innovative” SME for 2022

Good News - DiQi Pharma Recognized as a 2022 ‘Specialized, Refined, Distinctive, and Innovative’ SME
2022/04/21Congratulations to DiQi Pharma for Obtaining MAH Drug Manufacturing License!

In this season of spring blossoms and warm weather, DiQi Pharma has ushered in its harvest season ahead of schedule. On April 11, 2022, the Guangdong Provincial Drug Administration officially issued the Drug Manufacturing License to DiQi Pharma This marks the formal entry of DiQi Pharma's independently developed and proprietary products into commercial production, representing a significant milestone in the transformation of the company's R&D achievements.
2022/03/11DiQi Pharma Successfully Hosts 2022 International Women's Day Celebration and March Birthday Party

To celebrate International Women's Day and enrich employees' leisure time, Diqi Pharma held a celebration for International Women's Day and a March birthday party on March 8th.
2022/02/23Congratulations to DiQi Pharma for Being Recognized as a National High-Tech Enterprise for the Third Consecutive Time

On February 14, 2022, according to the “Notice on Filing and Publicizing the Third Batch of High-Tech Enterprises Recognized in Guangdong Province in 2021” issued by the National High-Tech Enterprise Work Network, Guangzhou Diqi Pharmaceuticals Co., Ltd. was once again recognized as a National High-Tech Enterprise, with the enterprise number: GR202144011675.

1 2 3 4 5

Contact Information

Address:8 Luoxuan 3rd Road, Guangzhou International BIO-island

Main telephone number:020-32227031

Fax:020-32227031

Email:gzdq@gzdqyy.com
Customer Service

Postal Code:510300

Business Consulting:18122367150 13602749876

Complaints Hotline:020-32227031

Complaint Email:diqiyjx@gzdqyy.com

Official WeChat

top